RDA Financial Network
IBB icon

RDA Financial Network’s iShares Biotechnology ETF IBB Stock Holding History

RDA Financial Network’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$262K Sell
1,245
-23
-2% -$4.62K 0.06% 224
2026
Q2 		$241K Sell
1,268
-27
-2% -$4.64K 0.05% 257
2026
Q1 		$219K Sell
1,295
-4
-0.3% -$684 0.05% 253
2025
Q4 		$219K Sell
1,299
-101
-7% -$16.4K 0.05% 245
2025
Q3 		$202K Sell
1,400
-247
-15% -$33.7K 0.05% 255
2025
Q2 		$208K Sell
1,647
-35
-2% -$4.3K 0.06% 249
2025
Q1 		$215K Sell
1,682
-3
-0.2% -$407 0.06% 234
2024
Q4 		$223K Sell
1,685
-2
-0.1% -$281 0.06% 226
2024
Q3 		$246K Sell
1,687
-140
-8% -$20.3K 0.08% 205
2024
Q2 		$251K Sell
1,827
-6
-0.3% -$801 0.08% 203
2024
Q1 		$252K Sell
1,833
-12
-0.7% -$1.64K 0.09% 202
2023
Q4 		$251K Sell
1,845
-17
-0.9% -$2.07K 0.1% 189
2023
Q3 		$228K Sell
1,862
-12
-0.6% -$1.53K 0.1% 189
2023
Q2 		$238K Sell
1,874
-129
-6% -$16.8K 0.1% 194
2023
Q1 		$259K Sell
2,003
-29
-1% -$3.8K 0.12% 177
2022
Q4 		$267K Sell
2,032
-58
-3% -$7.5K 0.13% 162
2022
Q3 		$244K Sell
2,090
-110
-5% -$13.7K 0.13% 163
2022
Q2 		$259K Sell
2,200
-139
-6% -$16.5K 0.13% 160
2022
Q1 		$305K Sell
2,339
-85
-4% -$11.1K 0.13% 163
2021
Q4 		$370K Buy
2,424
+84
+4% +$13K 0.15% 151
2021
Q3 		$378K Sell
2,340
-13
-0.6% -$2.19K 0.17% 141
2021
Q2 		$385K Buy
2,353
+21
+0.9% +$3.24K 0.17% 139
2021
Q1 		$351K Sell
2,332
-96
-4% -$15.2K 0.15% 147
2020
Q4 		$368K Sell
2,428
-68
-3% -$9.7K 0.17% 141
2020
Q3 		$338K Buy
2,496
+396
+19% +$53.7K 0.15% 140
2020
Q2 		$287K Buy
2,100
+108
+5% +$13.8K 0.14% 154
2020
Q1 		$215K Sell
1,992
-154
-7% -$17.7K 0.13% 161
2019
Q4 		$252K Sell
2,146
-51
-2% -$5.69K 0.1% 202
2019
Q3 		$249K Buy
2,197
+231
+12% +$24.2K 0.11% 192
2019
Q2 		$212K Sell
1,966
-30
-2% -$3.19K 0.1% 206
2019
Q1 		$221K Buy
+1,996
New +$219K 0.1% 190

Other funds holding IBB

Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return
MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
Investment House LLC
Investment House LLC Redondo Beach, California $2.25B AUM 30.44% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Redstone Wealth Management
Redstone Wealth Management Oklahoma City, Oklahoma $159M AUM 31.94% 1-Year Est. Return
Folger Nolan Fleming Douglas Capital Management
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return
Decker Retirement Planning
Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

RDA Financial Network's IBB Position: Q3 2026 in Review

RDA Financial Network reduced its iShares Biotechnology ETF (IBB) stake by 1.8% in Q3 2026, selling an estimated $4.62K and leaving 1,245 shares worth $262K. The position accounts for 0.06% of the portfolio, ranked #224.

RDA Financial Network first reported a position in IBB in Q1 2019 and has held it in 31 quarters since. The position peaked at $385K in Q2 2021. 303 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • RDA Financial Network held 1,245 shares of iShares Biotechnology ETF worth $262K as of Q3 2026.
  • RDA Financial Network sold 23 iShares Biotechnology ETF shares in Q3 2026, an estimated $4.62K.
  • iShares Biotechnology ETF made up 0.06% of RDA Financial Network's portfolio in Q3 2026, its #224 holding.
  • RDA Financial Network first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 31 quarters since.
  • RDA Financial Network's iShares Biotechnology ETF position peaked at $385K in Q2 2021.
  • 303 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on RDA Financial Network's 13F filing for Q3 2026, filed 15 Oct 2026.